IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Oct 2025 (Vol: 2025, Issue: 10)

Next Issue >>

Section: Licensing
Novo Nordisk Expands Rare Disease Pipeline with US$2.4 B Omeros Partnership Published: 31 Oct-2025
By: Hitesh Udar
Abstract Fulltext:
Section: Mergers & Acquisitions
Pfizer Expands Obesity Portfolio with US$4.9 B Acquisition of Metsera Published: 3 Oct-2025
By: Shikha Kashyap
Abstract Fulltext:
Roche to Acquire 89bio and its FGF21 Analogue Lead Asset for US$3.5 B Published: 15 Oct-2025
By: Naini Anand
Abstract Fulltext:
BioCryst to Acquire Astria Therapeutics for up to US$700 M Published: 17 Oct-2025
By: Ayush Saxena
Abstract Fulltext:
Novo Nordisk Strengthens Metabolic Pipeline with US$5.2 B Acquisition of Akero Therapeutics Published: 22 Oct-2025
By: Swati Sharan
Abstract Fulltext:
Genmab Strengthens Oncology Pipeline with US$8 B Acquisition of Merus Published: 30 Oct-2025
By: Naini Anand
Abstract Fulltext:
Bristol Myers Squibb to Acquire Orbital Therapeutics and its RNA Platform for US$1.5 B Published: 30 Oct-2025
By: Swati Sharan
Abstract Fulltext:
Section: Research & Development
Takeda Signs US$11.4 B Oncology Partnership with Innovent Biologics Published: 28 Oct-2025
By: Lucy Haggerty
Abstract Fulltext:

PharmaDeals will be moved to a new platform by October 31, 2026. Please look out for an email from your IQVIA account manager by the end of September with details.

Login

Username:

Password:

Keep me logged in